EFFECTOR THERAPUTCS INC (EFTR) SEC filings
EFTR SEC filings moved a median of 0.00% by the close. EFTR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the EFTR overview →
31 measured EFTR SEC filing events.
Where these EFTR SEC filings landedvs 31 measured EFTR SEC filing reactions
| Middle 50% of EFTR SEC filing reactions | -2.98% to +4.42% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 EFTR SEC filing events with a measured close landed between -2.98% and +4.42%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT eFFECTOR Therapeutics, | SEC filing · Form EFFECT | +0.00% | +1.21% | |
| Form 15-12G eFFECTOR Therapeutics, | SEC filing · Form 15-12G | +0.00% | +0.00% | |
| Form POS AM eFFECTOR Therapeutics, | SEC filing · Form POS | +0.00% | +0.00% | |
| Form S-8 POS eFFECTOR Therapeutics, | SEC filing · Form S-8 | +0.00% | +0.00% | |
| Form 8-K eFFECTOR Therapeutics, For: Jun 25 | SEC filing · Form 8-K | -1.74% | -11.80% | |
| Form 8-K eFFECTOR Therapeutics, For: Jun 24 | SEC filing · Form 8-K | -1.74% | -11.80% | |
| Form 8-K eFFECTOR Therapeutics, For: Jun 21 | SEC filing · Form 8-K | +10.62% | -3.08% | |
| Form 8-K eFFECTOR Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +0.80% | -0.80% | |
| Form 8-K eFFECTOR Therapeutics, For: May 20 | SEC filing · Form 8-K | +1.55% | -3.11% | |
| Form 8-K eFFECTOR Therapeutics, For: May 16 | SEC filing · Form 8-K | +1.55% | -3.11% | |
| Form 10-Q eFFECTOR Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.19% | -2.87% | |
| Form 8-K eFFECTOR Therapeutics, For: May 09 | SEC filing · Form 8-K | +0.19% | -2.87% | |
| Form 8-K/A eFFECTOR Therapeutics, For: May 09 | SEC filing · Form 8-K | +0.19% | -2.87% | |
| Form ARS eFFECTOR Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.65% | +4.42% | |
| Form DEF 14A eFFECTOR Therapeutics, For: Jun 13 | SEC filing · Form DEF | +1.65% | +4.42% | |
| Form DEFA14A eFFECTOR Therapeutics, | SEC filing · Form DEFA14A | +1.65% | +4.42% | |
| Form PRE 14A eFFECTOR Therapeutics, For: Jun 13 | SEC filing · Form PRE | +1.44% | +5.29% | |
| Form 8-K eFFECTOR Therapeutics, For: Apr 04 | SEC filing · Form 8-K | -6.11% | -17.78% | |
| Form EFFECT eFFECTOR Therapeutics, | SEC filing · Form EFFECT | -1.25% | +7.93% | |
| Form POS AM eFFECTOR Therapeutics, | SEC filing · Form POS | -0.69% | +9.05% | |
| Form S-8 eFFECTOR Therapeutics, | SEC filing · Form S-8 | -0.69% | +9.05% | |
| Form 10-K eFFECTOR Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.87% | +5.04% | |
| Form 8-K eFFECTOR Therapeutics, For: Mar 25 | SEC filing · Form 8-K | +1.87% | +5.04% | |
| Form 8-K eFFECTOR Therapeutics, For: Jan 29 | SEC filing · Form 8-K | +3.94% | -1.05% | |
| Form 8-K eFFECTOR Therapeutics, For: Jan 24 | SEC filing · Form 8-K | +0.91% | +12.18% | |
| Form 8-K eFFECTOR Therapeutics, For: Jan 09 | SEC filing · Form 8-K | -1.51% | -2.63% | |
| Form 8-K eFFECTOR Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -1.80% | +1.32% | |
| Form 8-K eFFECTOR Therapeutics, For: Dec 08 | SEC filing · Form 8-K | -3.68% | -10.70% | |
| Form 8-K eFFECTOR Therapeutics, For: Nov 28 | SEC filing · Form 8-K | -3.69% | -8.51% | |
| Form 10-Q eFFECTOR Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.57% | +0.73% | |
| Form 8-K eFFECTOR Therapeutics, For: Nov 13 | SEC filing · Form 8-K | +3.57% | +0.73% |
Keep exploring
More EFTR: earnings → · analyst actions → · EFTR overview →